RNTX: Rein Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 42.47
Enterprise Value ($M) 69.82
Book Value ($M) 95.23
Book Value / Share 4.40
Price / Book 0.45
NCAV ($M) 9.70
NCAV / Share 0.45
Price / NCAV 4.38

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.28
Return on Equity (ROE) -0.30

Liquidity (mrq)
Quick Ratio 3.30
Current Ratio 3.30

Balance Sheet (mrq) ($M)
Current Assets 18.68
Assets 104.22
Liabilities 8.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-05 13G/A University Of Texas/texas Am Investment Managment Co
04-16 13D/A Satter Muneer A 4.90 -18.34
02-14 13G/A Biotechnology Value Fund L P 0.00 -100.00
2024-02-05 13G/A Kapnick Scott 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 31,634 71,913 43.99
2025-02-03 20,985 41,605 50.44
2025-01-31 7,465 63,779 11.70
2025-01-30 31,771 221,677 14.33

(click for more detail)

Similar Companies
RGLS – Regulus Therapeutics Inc. RMTI – Rockwell Medical, Inc.
RNAZ – TransCode Therapeutics, Inc. RNXT – RenovoRx, Inc.
RVPH – Reviva Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io